一种生成治疗幼稚活检衍生的弥漫性固有脑桥胶质瘤和弥漫性中线胶质瘤模型的方案

{"title":"一种生成治疗幼稚活检衍生的弥漫性固有脑桥胶质瘤和弥漫性中线胶质瘤模型的方案","authors":"","doi":"10.33696/neurol.1.025","DOIUrl":null,"url":null,"abstract":"Diffuse intrinsic pontine glioma (DIPG) is a universally fatal tumor of the brainstem, most commonly affecting young children. Due to its location, surgical resection is not achievable, but consideration of a biopsy has become standard practice at children’s hospitals with the appropriate neurosurgical expertise. While the decision to obtain a biopsy should be directed by the presence of atypical radiographic features that call the diagnosis of DIPG into question or the requirement of biopsy tissue for clinical trial enrollment, once this precious tissue is available its use for research should be considered. The majority of DIPG and diffuse midline glioma, H3 K27Mmutant (DMG) models are autopsy-derived or genetically-engineered, each of which has limitations for translational studies, so the use of biopsy tissue for laboratory model development provides an opportunity to create unique model systems. Here, we present a detailed laboratory protocol for the generation of treatment-naïve biopsy-derived DIPG/DMG models. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/ licenses/by/4.0/ Correspondence should be addressed to Nicholas A. Vitanza; nicholas.vitanza@seattlechildrens.org. Authorship MCB, AN, CM, SMM, CAW, FP, JMO, and NAV participated in the design or interpretation of the reported experiments or results. MCB, AN, CM, SMM, CAW, FP, BLC, SRB, and NAV participated in the acquisition or analysis of data. MCB, AN, and NAV wrote the manuscript with revisions and approval from all authors. NAV supervised all aspects of the research. Conflicts of Interest None. HHS Public Access Author manuscript J Exp Neurol. Author manuscript; available in PMC 2021 March 24. Published in final edited form as: J Exp Neurol. 2020 December ; 1(4): 158–167. doi:10.33696//Neurol.1.025. A uhor M anscript","PeriodicalId":73744,"journal":{"name":"Journal of experimental neurology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A Protocol for the Generation of Treatment-naïve Biopsyderived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models\",\"authors\":\"\",\"doi\":\"10.33696/neurol.1.025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Diffuse intrinsic pontine glioma (DIPG) is a universally fatal tumor of the brainstem, most commonly affecting young children. Due to its location, surgical resection is not achievable, but consideration of a biopsy has become standard practice at children’s hospitals with the appropriate neurosurgical expertise. While the decision to obtain a biopsy should be directed by the presence of atypical radiographic features that call the diagnosis of DIPG into question or the requirement of biopsy tissue for clinical trial enrollment, once this precious tissue is available its use for research should be considered. The majority of DIPG and diffuse midline glioma, H3 K27Mmutant (DMG) models are autopsy-derived or genetically-engineered, each of which has limitations for translational studies, so the use of biopsy tissue for laboratory model development provides an opportunity to create unique model systems. Here, we present a detailed laboratory protocol for the generation of treatment-naïve biopsy-derived DIPG/DMG models. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/ licenses/by/4.0/ Correspondence should be addressed to Nicholas A. Vitanza; nicholas.vitanza@seattlechildrens.org. Authorship MCB, AN, CM, SMM, CAW, FP, JMO, and NAV participated in the design or interpretation of the reported experiments or results. MCB, AN, CM, SMM, CAW, FP, BLC, SRB, and NAV participated in the acquisition or analysis of data. MCB, AN, and NAV wrote the manuscript with revisions and approval from all authors. NAV supervised all aspects of the research. Conflicts of Interest None. HHS Public Access Author manuscript J Exp Neurol. Author manuscript; available in PMC 2021 March 24. Published in final edited form as: J Exp Neurol. 2020 December ; 1(4): 158–167. doi:10.33696//Neurol.1.025. A uhor M anscript\",\"PeriodicalId\":73744,\"journal\":{\"name\":\"Journal of experimental neurology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of experimental neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33696/neurol.1.025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of experimental neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33696/neurol.1.025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

弥漫性固有桥脑胶质瘤(DIPG)是一种普遍致命的脑干肿瘤,最常见于幼儿。由于其位置,手术切除是不可能实现的,但考虑活检已成为具有适当神经外科专业知识的儿童医院的标准做法。虽然活检的决定应该根据是否存在非典型放射学特征来决定,这些特征会使DIPG的诊断受到质疑,或者临床试验注册需要活检组织,但一旦这种珍贵的组织可用,就应该考虑将其用于研究。大多数DIPG和弥漫性中线神经胶质瘤H3 K27M突变体(DMG)模型都是尸检衍生或基因工程模型,每种模型都有转化研究的局限性,因此使用活检组织进行实验室模型开发为创建独特的模型系统提供了机会。在这里,我们提出了一个详细的实验室方案,用于生成治疗幼稚的活检衍生的DIPG/DMG模型。这是一篇根据知识共享署名许可证条款分发的开放获取文章,该许可证允许在任何媒体上不受限制地使用、分发和复制,前提是原始作者和来源得到认可。http://creativecommons.org/许可证/截止日期/4.0/通讯地址应为Nicholas A.Vitanza;nicholas.vitanza@seattlechildrens.org.作者MCB、AN、CM、SMM、CAW、FP、JMO和NAV参与了报告的实验或结果的设计或解释。MCB、AN、CM、SMM、CAW、FP、BLC、SRB和NAV参与了数据的采集或分析。MCB、AN和NAV在所有作者的修订和批准下撰写了手稿。NAV监督了研究的各个方面。利益冲突无。HHS公共访问作者手稿J Exp Neurol。作者手稿;可于2021年3月24日在PMC上获得。以最终编辑形式出版:《神经实验杂志》。2020年12月;1(4):158–167。doi:10.33696//Neurol.1.025
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Protocol for the Generation of Treatment-naïve Biopsyderived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models
Diffuse intrinsic pontine glioma (DIPG) is a universally fatal tumor of the brainstem, most commonly affecting young children. Due to its location, surgical resection is not achievable, but consideration of a biopsy has become standard practice at children’s hospitals with the appropriate neurosurgical expertise. While the decision to obtain a biopsy should be directed by the presence of atypical radiographic features that call the diagnosis of DIPG into question or the requirement of biopsy tissue for clinical trial enrollment, once this precious tissue is available its use for research should be considered. The majority of DIPG and diffuse midline glioma, H3 K27Mmutant (DMG) models are autopsy-derived or genetically-engineered, each of which has limitations for translational studies, so the use of biopsy tissue for laboratory model development provides an opportunity to create unique model systems. Here, we present a detailed laboratory protocol for the generation of treatment-naïve biopsy-derived DIPG/DMG models. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/ licenses/by/4.0/ Correspondence should be addressed to Nicholas A. Vitanza; nicholas.vitanza@seattlechildrens.org. Authorship MCB, AN, CM, SMM, CAW, FP, JMO, and NAV participated in the design or interpretation of the reported experiments or results. MCB, AN, CM, SMM, CAW, FP, BLC, SRB, and NAV participated in the acquisition or analysis of data. MCB, AN, and NAV wrote the manuscript with revisions and approval from all authors. NAV supervised all aspects of the research. Conflicts of Interest None. HHS Public Access Author manuscript J Exp Neurol. Author manuscript; available in PMC 2021 March 24. Published in final edited form as: J Exp Neurol. 2020 December ; 1(4): 158–167. doi:10.33696//Neurol.1.025. A uhor M anscript
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信